Literature DB >> 25123173

Cannabinoid-mediated short-term plasticity in hippocampus.

Margarita Zachariou1, Rüdiger Thul.   

Abstract

Endocannabinoids (eCBs) modulate both excitatory and inhibitory neurotransmission in hippocampus via activation of pre-synaptic cannabinoid receptors. Here, we present a model for cannabinoid mediated short-term depression of excitation (DSE) based on our recently developed model for the equivalent phenomenon of suppressing inhibition (DSI). Furthermore, we derive a simplified formulation of the calcium-mediated endocannabinoid synthesis that underlies short-term modulation of neurotransmission in hippocampus. The simplified model describes cannabinoid-mediated short-term modulation of both hippocampal inhibition and excitation and is ideally suited for large network studies. Moreover, the implementation of the simplified DSI/DSE model provides predictions on how both phenomena are modulated by the magnitude of the pre-synaptic cell's activity. In addition we demonstrate the role of DSE in shaping the post-synaptic cell's firing behaviour qualitatively and quantitatively in dependence on eCB availability and the pre-synaptic cell's activity. Finally, we explore under which conditions the combination of DSI and DSE can temporarily shift the fine balance between excitation and inhibition. This highlights a mechanism by which eCBs might act in a neuro-protective manner during high neural activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25123173     DOI: 10.1007/s10827-014-0518-4

Source DB:  PubMed          Journal:  J Comput Neurosci        ISSN: 0929-5313            Impact factor:   1.621


  32 in total

Review 1.  The endocannabinoid system as a target for therapeutic drugs.

Authors:  D Piomelli; A Giuffrida; A Calignano; F Rodríguez de Fonseca
Journal:  Trends Pharmacol Sci       Date:  2000-06       Impact factor: 14.819

2.  ModelDB: A Database to Support Computational Neuroscience.

Authors:  Michael L Hines; Thomas Morse; Michele Migliore; Nicholas T Carnevale; Gordon M Shepherd
Journal:  J Comput Neurosci       Date:  2004 Jul-Aug       Impact factor: 1.621

Review 3.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model.

Authors:  X J Wang; G Buzsáki
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

5.  Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.

Authors:  Bin Pan; Wei Wang; Peng Zhong; Jacqueline L Blankman; Benjamin F Cravatt; Qing-song Liu
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

6.  COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation.

Authors:  A Straiker; J Wager-Miller; S S Hu; J L Blankman; B F Cravatt; K Mackie
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

7.  Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells.

Authors:  Lindsey L Glickfeld; Massimo Scanziani
Journal:  Nat Neurosci       Date:  2006-04-30       Impact factor: 24.884

8.  Evidence for endogenous excitatory amino acids as mediators in DSI of GABA(A)ergic transmission in hippocampal CA1.

Authors:  W Morishita; B E Alger
Journal:  J Neurophysiol       Date:  1999-11       Impact factor: 2.714

9.  Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.

Authors:  Juan Guo; Stephen R Ikeda
Journal:  Mol Pharmacol       Date:  2004-03       Impact factor: 4.436

10.  Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus.

Authors:  Jimok Kim; Bradley E Alger
Journal:  Nat Neurosci       Date:  2004-06-06       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.